Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion

1998 ◽  
Vol 362 (2-3) ◽  
pp. 137-142 ◽  
Author(s):  
Hiroyuki Takamatsu ◽  
Kazunao Kondo ◽  
Yasuhiko Ikeda ◽  
Kazuo Umemura
2000 ◽  
Vol 39 (2) ◽  
pp. 211-217 ◽  
Author(s):  
Sachiko Kawasaki-Yatsugi ◽  
Chikako Ichiki ◽  
Shin-ichi Yatsugi ◽  
Masayasu Takahashi ◽  
Masao Shimizu-Sasamata ◽  
...  

2009 ◽  
Vol 29 (4) ◽  
pp. 675-687 ◽  
Author(s):  
Ashuthosh Dharap ◽  
Kellie Bowen ◽  
Robert Place ◽  
Long-Cheng Li ◽  
Raghu Vemuganti

MicroRNAs (miRNAs) are ∼22 nucleotides long, noncoding RNAs that control cellular function by either degrading mRNAs or arresting their translation. To understand their functional significance in ischemic pathophysiology, we profiled miRNAs in adult rat brain as a function of reperfusion time after transient middle cerebral artery occlusion. Of the 238 miRNAs evaluated, 8 showed increased and 12 showed decreased expression at least at 4 out of 5 reperfusion time points studied between 3 h and 3 days compared with sham. Of those, 17 showed > 5 fold change. Bioinformatics analysis indicated a correlation between miRNAs altered to several mRNAs known to mediate inflammation, transcription, neuroprotection, receptors function, and ionic homeostasis. Antagomir-mediated prevention of mir-145 expression led to an increased protein expression of its downstream target superoxide dismutase-2 in the postischemic brain. In silico analysis showed sequence complementarity of eight miRNAs induced after focal ischemia to 877 promoters indicating the possibility of noncoding RNA-induced activation of gene expression. The mRNA expression of the RNases Drosha and Dicer, cofactor Pasha, and the pre-miRNA transporter exportin-5, which modulate miRNA biogenesis, were not altered after transient middle cerebral artery occlusion. Thus, the present studies indicate a critical role of miRNAs in controlling mRNA transcription and translation in the postischemic brain.


2010 ◽  
Vol 13 (4) ◽  
pp. 607 ◽  
Author(s):  
Dorothee Lang ◽  
Christian Ude ◽  
Mario Wurglics ◽  
Manfred Schubert-Zsilavecz ◽  
Jochen Klein

ABSTRACT. Purpose. Bilobalide is an active constituent of Ginkgo biloba and has shown neuroprotective effects in mice with cerebral ischemia. In the present study, we investigated brain permeability of bilobalide (i) in healthy mice and (ii) in mice before or after stroke. Methods. We have used in vivo microdialysis and LC-MS to estimate extracellular levels of bilobalide. 10 mg/kg of bilobalide was given by i.p. injection to control mice, and 60 minutes before and after middle cerebral artery occlusion (MCAO). Results. Bilobalide was already detectable in brain striatal microdialysates 10 min after i.p. administration and reached maximum levels (19 ng/mL, corresponding to 0.92 µM) after 40 min. Maximum plasma bilobalide levels were 5.9 µM. After an ischemic insult, the drug could be dialysed with similar efficiency as in control mice indicating slow elimination from the ischemic brain. When the drug was given after MCAO, availability in the brain was low, but measurable, at approx. 10% of control values. Conclusions. Our data demonstrate that bilobalide easily crosses the blood brain barrier and reaches extracellular concentrations in the brain that allow efficient interaction with target molecules such as neurotransmitter receptors. Availability of the drug in ischemic tissue is high when given before ischemia, but severely limited after MCAO.


Sign in / Sign up

Export Citation Format

Share Document